PAK4 and non-small cell lung carcinoma: To further confirm whether PAK4 levels were elevated in cisplatin-resistant NSCLC tissues, 159 human NSCLC tissues (55 tissues sensitive to cisplatin and 104 tissues resistant to it) were stained immunohistochemically.